The error is something more consequential than that. m-enoxaparin was an internal code name; now that the product is approved for marketing, the companies will presumably drop the "m" and go with just enoxaparin.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”